Literature DB >> 30594268

Respiratory Viral Infection: An Underappreciated Cause of Acute Febrile Illness Admissions in Southern Sri Lanka.

L Gayani Tillekeratne1,2,3, Champica K Bodinayake4,3, Ryan Simmons2, Ajith Nagahawatte4,3, Vasantha Devasiri4,3, Wasantha Kodikara Arachchi5,3, Bradly P Nicholson3,1, Lawrence P Park2,1, Sky Vanderburg3,1, Ruvini Kurukulasooriya3, Aruna Dharshan De Silva6,3, Truls Østybe3,2,1, Megan E Reller3,2,1, Christopher W Woods3,2,1.   

Abstract

The contribution of respiratory viruses to acute febrile illness (AFI) burden is poorly characterized. We describe the prevalence, seasonality, and clinical features of respiratory viral infection among AFI admissions in Sri Lanka. We enrolled AFI patients ≥ 1 year of age admitted to a tertiary care hospital in southern Sri Lanka, June 2012-October 2014. We collected epidemiologic/clinical data and a nasal or nasopharyngeal sample that was tested using polymerase chain reaction (Luminex NxTAG, Austin, TX). We determined associations between weather data and respiratory viral activity using the Spearman correlation and assessed respiratory virus seasonality using a Program for Appropriate Technology definition. Bivariable and multivariable regression analyses were conducted to identify features associated with respiratory virus detection. Among 964 patients, median age was 26.2 years (interquartile range 14.6-39.9) and 646 (67.0%) were male. One-fifth (203, 21.1%) had respiratory virus detected: 13.9% influenza, 1.4% human enterovirus/rhinovirus, 1.4% parainfluenza virus, 1.1% respiratory syncytial virus, and 1.1% human metapneumovirus. Patients with respiratory virus identified were younger (median 9.8 versus 27.7 years, P < 0.001) and more likely to have respiratory signs and symptoms. Influenza A and respiratory viral activity peaked in February-June each year. Maximum daily temperature was associated with influenza and respiratory viral activity (P = 0.03 each). Patients with respiratory virus were as likely as others to be prescribed antibiotics (55.2% versus 52.6%, P = 0.51), and none reported prior influenza vaccination. Respiratory viral infection was a common cause of AFI. Improved access to vaccines and respiratory diagnostics may help reduce disease burden and inappropriate antibiotic use.

Entities:  

Mesh:

Year:  2019        PMID: 30594268      PMCID: PMC6402941          DOI: 10.4269/ajtmh.18-0699

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  4 in total

1.  Previously Derived Host Gene Expression Classifiers Identify Bacterial and Viral Etiologies of Acute Febrile Respiratory Illness in a South Asian Population.

Authors:  L Gayani Tillekeratne; Sunil Suchindran; Emily R Ko; Elizabeth A Petzold; Champica K Bodinayake; Ajith Nagahawatte; Vasantha Devasiri; Ruvini Kurukulasooriya; Bradly P Nicholson; Micah T McClain; Thomas W Burke; Ephraim L Tsalik; Ricardo Henao; Geoffrey S Ginsburg; Megan E Reller; Christopher W Woods
Journal:  Open Forum Infect Dis       Date:  2020-05-26       Impact factor: 3.835

2.  Viral burden and diversity in acute respiratory tract infections in hospitalized children in wet and dry zones of Sri Lanka.

Authors:  J A A S Jayaweera; A J Morel; A M S B Abeykoon; F N N Pitchai; H S Kothalawela; J S M Peiris; F Noordeen
Journal:  PLoS One       Date:  2021-12-17       Impact factor: 3.240

3.  Clinical and epidemiological characteristics of influenza virus infection in hospitalized children with acute respiratory infections in Sri Lanka.

Authors:  Rukshan A M Rafeek; Maduja V M Divarathna; Adrian J Morel; Faseeha Noordeen
Journal:  PLoS One       Date:  2022-09-02       Impact factor: 3.752

4.  Outbreak of severe acute respiratory infection in Southern Province, Sri Lanka in 2018: a cross-sectional study.

Authors:  Sky Vanderburg; Gaya Wijayaratne; Nayomi Danthanarayana; Jude Jayamaha; Bhagya Piyasiri; Chathurangi Halloluwa; Tianchen Sheng; Sujeewa Amarasena; Ruvini Kurukulasooriya; Bradly P Nicholson; Joseph S M Peiris; Gregory C Gray; Sunethra Gunasena; Ajith Nagahawatte; Champica K Bodinayake; Christopher W Woods; Vasantha Devasiri; L Gayani Tillekeratne
Journal:  BMJ Open       Date:  2020-11-06       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.